BRAF and adenoma: However, a major distinction in this parallelism is that Wnt-pathway-activating APC mutations have precursor roles in the adenoma–carcinoma pathway, while in the serrated pathway, the Wnt-pathway-activating mutations mentioned above most likely occur after BRAF mutations.